These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 9513907

  • 1. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.
    J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 3. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M, Grcevska L, Dzikova S.
    Prilozi; 2006 Dec 05; 27(2):5-12. PubMed ID: 17211287
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 Dec 05; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 5. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb 05; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 6. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B.
    N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953
    [Abstract] [Full Text] [Related]

  • 7. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C.
    Kidney Int; 1995 Nov 27; 48(5):1600-4. PubMed ID: 8544420
    [Abstract] [Full Text] [Related]

  • 8. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
    Ardiles LG, Mezzano SA.
    Clin Nephrol; 1996 Jun 27; 45(6):423. PubMed ID: 8793243
    [No Abstract] [Full Text] [Related]

  • 9. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
    Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of the nephrotic syndrome with cyclosporin A.
    Ponticelli C.
    J Autoimmun; 1992 Apr 01; 5 Suppl A():315-24. PubMed ID: 1503627
    [Abstract] [Full Text] [Related]

  • 13. Corticosteroids, cyclophosphamide, and chlorambucil therapy of membranous nephropathy.
    Passerini P, Ponticelli C.
    Semin Nephrol; 2003 Jul 01; 23(4):355-61. PubMed ID: 12923723
    [Abstract] [Full Text] [Related]

  • 14. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov 01; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 15. Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.
    van den Brand JAJG, Ruggenenti P, Chianca A, Hofstra JM, Perna A, Ruggiero B, Wetzels JFM, Remuzzi G.
    J Am Soc Nephrol; 2017 Sep 01; 28(9):2729-2737. PubMed ID: 28487395
    [Abstract] [Full Text] [Related]

  • 16. Idiopathic Membranous Nephropathy and Treatment Related Complications.
    Uncanin S, Dzemidzic J, Serdarevic N, Muslimovic A, Haskovic D.
    Med Arch; 2020 Jun 01; 74(3):228-232. PubMed ID: 32801441
    [Abstract] [Full Text] [Related]

  • 17. Treatment of membranous lupus nephritis.
    Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C.
    Am J Kidney Dis; 1998 Apr 01; 31(4):681-6. PubMed ID: 9531186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.